MINI FUTURE SHORT - BAVARIAN NORDIC Stock

Certificat

MFSBAVANOND96

DK0062198453

Market Closed - Nasdaq Copenhagen 03:18:51 2023-09-01 EDT
100.5 ^DKK	+14.22%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BAVARIAN NORDIC A/S

Chart MINI FUTURE SHORT - BAVARIAN NORDIC

Latest news about BAVARIAN NORDIC A/S

Bavarian Nordic Files for Supplemental US License for Smallpox-Monkeypox Vaccine	05-31	MT
Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Smallpox and Mpox Vaccine	05-31	GL
Bavarian Nordic Gets $6.5 Million Funding for Development of Mpox Vaccine in Children	05-30	MT
Bavarian Nordic and CEPI Partners to Advance Mpox Vaccination in Africa	05-30	GL

More news

Static data

Product type	Knock-Out with Stop Loss
Buy / Sell	PUT
Underlying	BAVARIAN NORDIC A/S
Issuer	Nordea
	MFSBAVANOND96
ISIN	DK0062198453
Date issued	2023-05-03
Strike	251.7 kr
Maturity	Unlimited
Parity	1 : 1
Emission price	- kr
Emission volume	N/A
Settlement	cash
Currency	DKK

Technical Indicators

Highest since issue	100.5 kr
Lowest since issue	87.99 kr
Spread	1.2 kr
Spread %	1.79%

Company Profile

Bavarian Nordic A/S specializes in the development, manufacturing and commercialization of cancer immunotherapies and vaccines for the prevention and treatment of infectious diseases. Net sales by revenue source are divided between sales of products (97.8%) and services (2.2%). Net sales are distributed geographically as follows: the United States (36.5%), Canada (22%), France (10.5%), Germany (10.1%), Spain (6.1%), Australia (4.8%), Switzerland ( 1.5%), Sweden (1%), Chile (0.9%), Taiwan (0.8%), the United Kingdom (0.6%), Hong Kong (0.2%), Saudi Arabia (0.1%), and others (4.9%).

Sector

More about the company